Publication | Closed Access

Integrated contrast-enhanced diagnostic whole-body PET/CT as a first-line restaging modality in patients with suspected metastatic recurrence of breast cancer

EngineeringOncologic ImagingMedical ImagingPet-mriFirst-line Restaging ModalityBiomedical ImagingBreast ImagingBreast CancerSuspected Metastatic RecurrenceRadiation OncologyOncologyMolecular ImagingNuclear MedicineRadiologyHealth Sciences